Methods for preventing and treating Alzheimer's disease
US7732568B2 · kind B2 · utility
10Cited by
2References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 13, 2004 |
| Grant date | Jun 8, 2010 |
| Priority date | — |
| Expiry date | Jun 17, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for preventing and treating Alzheimer's disease (AD). An Aβ42 mimotope is used for vaccination against AD. The mimotope induces the production of antibodies against Aβ42 but not against the native APP. The mimotope is functionally similar to, but not structurally identical with DAEFRH (SEQ ID NO: 1) which is a part of the naturally-occurring Aβ42 sequence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.